Developmental disruption of the mitochondrial fission gene drp-1 extends the longevity of daf-2 insulin/IGF-1 receptor mutant

被引:0
|
作者
Traa, Annika [1 ,2 ,3 ]
Gonzalez, Aura A. Tamez [1 ,2 ,3 ]
Van Raamsdonk, Jeremy M. [1 ,2 ,3 ,4 ]
机构
[1] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada
[2] McGill Univ, Hlth Ctr, Res Inst, Metab Disorders & Complicat Program, Montreal, PQ, Canada
[3] McGill Univ, Res Inst, Brain Repair & Integrat Neurosci Program, Hlth Ctr, Montreal, PQ, Canada
[4] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
Aging; Mitochondrial fission; C; elegans; Insulin/IGF-1; signaling; DRP1; Biological resilience; OXIDATIVE STRESS RESISTANCE; DYNAMIN-RELATED PROTEIN-1; INCREASE LIFE-SPAN; C; ELEGANS; CAENORHABDITIS-ELEGANS; PROVIDES NEUROPROTECTION; AMYLOID-BETA; CELL-DEATH; DYSFUNCTION; MITOPHAGY;
D O I
10.1007/s11357-024-01276-z
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The dynamic nature of the mitochondrial network is regulated by mitochondrial fission and fusion, allowing for re-organization of mitochondria to adapt to the cell's ever-changing needs. As organisms age, mitochondrial fission and fusion become dysregulated and mitochondrial networks become increasingly fragmented. Modulation of mitochondrial dynamics has been shown to affect longevity in fungi, yeast, Drosophila and C. elegans. Disruption of the mitochondrial fission gene drp-1 drastically increases the already long lifespan of daf-2 insulin/IGF-1 signaling (IIS) mutants. In this work, we determined the conditions required for drp-1 disruption to extend daf-2 longevity and explored the molecular mechanisms involved. We found that knockdown of drp-1 during development is sufficient to extend daf-2 lifespan, while tissue-specific knockdown of drp-1 in neurons, intestine or muscle failed to increase daf-2 longevity. Disruption of other genes involved in mitochondrial fission also increased daf-2 lifespan as did treatment with RNA interference clones that decrease mitochondrial fragmentation. In exploring potential mechanisms involved, we found that deletion of drp-1 increases resistance to chronic stresses. In addition, we found that disruption of drp-1 increased mitochondrial and peroxisomal connectedness in daf-2 worms, increased oxidative phosphorylation and ATP levels, and increased mitophagy in daf-2 worms, but did not affect their ROS levels, food consumption or mitochondrial membrane potential. Disruption of mitophagy through RNA interference targeting pink-1 decreased the lifespan of daf-2;drp-1 worms suggesting that increased mitophagy contributes to their extended lifespan. Overall, this work defined the conditions under which drp-1 disruption increases daf-2 lifespan and has identified multiple changes in daf-2;drp-1 mutants that may contribute to their lifespan extension.
引用
收藏
页码:877 / 902
页数:26
相关论文
共 50 条
  • [21] The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting
    Shoshana Yakar
    Hyunsook Kim
    Hong Zhao
    Yuka Toyoshima
    Patricia Pennisi
    Oksana Gavrilova
    Derek LeRoith
    Pediatric Nephrology, 2005, 20 : 251 - 254
  • [22] pkc-1 regulates daf-2 insulin/IGF signalling-dependent control of dauer formation in Caenorhabditis elegans
    Monje, Jose M.
    Brokate-Llanos, Ana M.
    Perez-Jimenez, Mercedes M.
    Fidalgo, Manuel A.
    Munoz, Manuel J.
    AGING CELL, 2011, 10 (06) : 1021 - 1031
  • [23] Emodin extends lifespan of Caenorhabditis elegans through insulin/IGF-1 signaling pathway depending on DAF-16 and SIR-2.1
    Zhao, Xuan
    Lu, Lulu
    Qi, Yonghao
    Li, Miao
    Zhou, Lijun
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2017, 81 (10) : 1908 - 1916
  • [24] Direct actions of insulin on osteoblasts revealed by cre-mediated disruption of the IGF-1 receptor.
    Fulzele, K.
    DiGirolamo, D. J.
    Liu, Z.
    Xu, J.
    Messina, J. L.
    Clemens, T. L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S14 - S14
  • [25] Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C-elegans insulin gene family
    Pierce, SB
    Costa, M
    Wisotzkey, R
    Devadhar, S
    Homburger, SA
    Buchman, AR
    Ferguson, KC
    Heller, J
    Platt, DM
    Pasquinelli, AA
    Liu, LX
    Doberstein, SK
    Ruvkun, G
    GENES & DEVELOPMENT, 2001, 15 (06) : 672 - 686
  • [26] THE INSULIN-LIKE GROWTH FACTOR-I (IGF-1) RECEPTOR IS RESPONSIBLE FOR MEDIATING THE EFFECTS OF INSULIN, IGF-1, AND IGF-2 IN XENOPUS-LAEVIS OOCYTES
    JANICOT, M
    FLORESRIVEROS, JR
    LANE, MD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (15) : 9382 - 9391
  • [27] A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression
    Chrudinova, Martina
    Kirk, Nicholas S.
    Chuard, Aurelien
    Venugopal, Hari
    Zhang, Fa
    Lubos, Marta
    Gelfanov, Vasily
    Panikova, Terezie
    Zakova, Lenka
    Cutone, Julianne
    Mojares, Matthew
    DiMarchi, Richard
    Jiracek, Jiri
    Altindis, Emrah
    MOLECULAR METABOLISM, 2024, 80
  • [28] LC-MS Proteomics Analysis of the Insulin/IGF-1-Deficient Caenorhabditis elegans daf-2(e1370) Mutant Reveals Extensive Restructuring of Intermediary Metabolism
    Depuydt, Geert
    Xie, Fang
    Petyuk, Vladislav A.
    Smolders, Arne
    Brewer, Heather M.
    Camp, David G., II
    Smith, Richard D.
    Braeckman, Bart P.
    JOURNAL OF PROTEOME RESEARCH, 2014, 13 (04) : 1938 - 1956
  • [29] Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action
    Rabiee, Atefeh
    Krueger, Marcus
    Ardenkjaer-Larsen, Jacob
    Kahn, C. Ronald
    Emanuelli, Brice
    CELLULAR SIGNALLING, 2018, 47 : 1 - 15
  • [30] Real-time RT-PCR quantification of insulin-like growth factor (IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding proteins 1, 2 and 3 in the bovine species
    Pfaffl, MW
    Georgieva, TM
    Georgiev, IP
    Ontsouka, E
    Hageleit, M
    Blum, JW
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2002, 22 (02) : 91 - 102